These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26825332)

  • 1. Increased extracellular volume fraction in heart failure: does it indicate worse outcomes independently of medical therapy?
    Eyuboglu M
    J Cardiovasc Med (Hagerstown); 2016 Mar; 17(3):226-7. PubMed ID: 26825332
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy.
    Barison A; Emdin M; Masci PG
    J Cardiovasc Med (Hagerstown); 2016 Mar; 17(3):227. PubMed ID: 26825333
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy.
    Barison A; Del Torto A; Chiappino S; Aquaro GD; Todiere G; Vergaro G; Passino C; Lombardi M; Emdin M; Masci PG
    J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):681-7. PubMed ID: 26090916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFpEF: an enigma being slowly but surely unravelled.
    Lüscher TF
    Eur Heart J; 2019 Dec; 40(45):3659-3662. PubMed ID: 31786589
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathy.
    Rizzello V; Poldermans D; Biagini E; Schinkel AF; Elhendy A; Leone AM; Crea F; Maat A; Roelandt JR; Bax JJ
    Am J Cardiol; 2005 Aug; 96(3):386-9. PubMed ID: 16054464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concepts and questions in programming cardiac resynchronization devices.
    Scharf C; Attenhofer Jost CH
    Heart Rhythm; 2005 Oct; 2(10):1073-5. PubMed ID: 16188584
    [No Abstract]   [Full Text] [Related]  

  • 10. The frustrating search for arrhythmia risk stratifiers in heart failure due to nonischemic cardiomyopathy: does T-wave alternans testing help?
    Verrier RL; Kumar K; Josephson ME
    J Am Coll Cardiol; 2007 Nov; 50(19):1905-6. PubMed ID: 17980259
    [No Abstract]   [Full Text] [Related]  

  • 11. Right ventricular ejection fraction and left ventricular dyssynchrony by 3D echo correlate with functional impairment in patients with dilated cardiomyopathy.
    D'Andrea A; Gravino R; Riegler L; Salerno G; Scarafile R; Romano M; Cuomo S; Del Viscovo L; Ferrara I; De Rimini ML; Muto P; Limongelli G; Pacileo G; Bossone E; Russo MG; Calabrò R
    J Card Fail; 2011 Apr; 17(4):309-17. PubMed ID: 21440869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Left ventricular systolic dysfunction in cardiomyopathies].
    Bouhour JB; Langlard JM
    Arch Mal Coeur Vaiss; 1996 Jul; 89 Spec No 2():33-7. PubMed ID: 8881504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitral effective regurgitant orifice area versus left ventricular ejection fraction as prognostic indicators in patients with dilated cardiomyopathy and heart failure.
    Venturi F; Gianfaldoni ML; Melina G; Cecchi A; Petix NR; Monopoli A; Taiti A; Mazzoni V; Fantini F
    Ital Heart J; 2004 Oct; 5(10):755-61. PubMed ID: 15626272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and peripheral responses to exercise in patients with chronic heart failure.
    Cohen-Solal A; Logeart D; Guiti C; Dahan M; Gourgon R
    Eur Heart J; 1999 Jul; 20(13):931-45. PubMed ID: 10361045
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated overlapping ventriculoplasty combined with papillary muscle plication for severely dilated heart failure.
    Matsui Y; Fukada Y; Naito Y; Sasaki S
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1221-3. PubMed ID: 15052233
    [No Abstract]   [Full Text] [Related]  

  • 17. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
    Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices.
    Kusa S; Miller MA; Whang W; Enomoto Y; Panizo JG; Iwasawa J; Choudry S; Pinney S; Gomes A; Langan N; Koruth JS; d'Avila A; Reddy VY; Dukkipati SR
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28576780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.